Tracking A-T in babies and young children
Part of Brain & nervous system, Genetic & congenital, Heart & circulation, Hormones & metabolism, Immune system & allergy clinical trials.
This study is looking for very young children (under 2) with Ataxia Telangiectasia to help find better ways to track the disease using brain scans and other tests. If your child joins, they will have MRIs and other checkups over time to help researchers understand how A-T affects babies and toddlers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must have a confirmed genetic diagnosis of Ataxia Telangiectasia (A-T).
- Your child must be under 2 years old when they first join the study.
- Your child must be able to have an MRI (no metal implants, severe kidney problems, or allergy to contrast dye).
- Your child must not have any other brain or nerve disease besides A-T.
- Your child must not be on a treatment that specifically targets A-T brain damage, or be in a trial for such a treatment, at the start of this study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new genetic medicine designed for people with A-T who have a specific ATM gene change. It aims to see if the treatment is safe and if it can improve symptoms.
This study looks at how the brain “mirrors” or responds to actions, with the goal of finding early signs of neurodevelopmental disorders. It includes healthy adults and infants, and infants who may be at risk, to compare brain patterns early on.
This trial uses eye tracking to understand how children with Angelman syndrome perceive social cues. Participation helps researchers learn more about social perception for future treatments.
This study follows people with CTNNB1 syndrome over time to better understand the condition. It does not test any new treatment—just collects information to help future research.
This study looks at how social behaviors and brain connections develop in infants who have a higher or lower chance of developing autism. It helps doctors understand early signs and may lead to better support for children and families.
This study looks at rare genetic syndromes caused by changes in the RNU4ATAC or RTTN genes. It aims to understand how these changes affect the body by studying patients, their parents, and fetal tissue.
Hear when a new Ataxia Telangiectasia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.